Lipocine Inc. Files 8-K
Ticker: LPCN · Form: 8-K · Filed: Oct 2, 2024 · CIK: 1535955
| Field | Detail |
|---|---|
| Company | Lipocine Inc. (LPCN) |
| Form Type | 8-K |
| Filed Date | Oct 2, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Lipocine filed a routine 8-K on Oct 2nd. Nothing major disclosed.
AI Summary
Lipocine Inc. filed an 8-K on October 2, 2024, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive offices in Salt Lake City, Utah, previously operated under the name Marathon Bar Corp until November 30, 2011. The filing does not detail specific financial transactions or events beyond its routine reporting nature.
Why It Matters
This 8-K filing indicates Lipocine Inc. is fulfilling its regulatory reporting obligations, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and financial statements, with no immediate indication of significant risk or opportunity.
Key Players & Entities
- Lipocine Inc. (company) — Registrant
- Marathon Bar Corp (company) — Former company name
- October 2, 2024 (date) — Date of earliest event reported
- 675 Arapeen Drive, Suite 202 (location) — Principal executive offices address
- Salt Lake City, Utah (location) — Principal executive offices city and state
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates it is for 'Other Events' and 'Financial Statements and Exhibits', but the specific details of these events are not provided in the excerpt.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on October 2, 2024.
What was Lipocine Inc.'s former company name?
Lipocine Inc.'s former company name was Marathon Bar Corp.
On what date did the company change its name from Marathon Bar Corp?
The company changed its name from Marathon Bar Corp on November 30, 2011.
Where are Lipocine Inc.'s principal executive offices located?
Lipocine Inc.'s principal executive offices are located at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108.
Filing Stats: 448 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2024-10-02 09:35:10
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share LPCN The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 15KB
- form8-k_001.jpg (GRAPHIC) — 5KB
- 0001493152-24-039133.txt ( ) — 244KB
- lpcn-20241002.xsd (EX-101.SCH) — 3KB
- lpcn-20241002_lab.xml (EX-101.LAB) — 33KB
- lpcn-20241002_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIPOCINE INC. Date: October 2, 2024 By: /s/ Mahesh V. Patel Mahesh V. Patel President and Chief Executive Officer